CSE:LOBE

CSE Bulletin: Name and Symbol Change - GreenStar Biosciences Corp.

GreenStar Biosciences Corp. has announced a name and symbol change to Lobe Sciences Ltd. (LOBE)

Shares will begin trading under the new name and symbol and with a new CUSIP number on November 16, 2020.

Disclosure documents are available at www.thecse.com

Please note that all open orders will be cancelled at the end of business on November 13, 2020. Dealers are reminded to re-enter their orders.

_________________________________

GreenStar Biosciences Corp. a annoncé un changement de nom et de symbole pour Lobe Sciences Ltd. (LOBE)

Les actions commenceront à se négocier sous le nouveau nom et le nouveau symbole et avec un nouveau numéro CUSIP le 16 novembre 2020.

Les documents de divulgation sont disponibles sur www.thecse.com

Veuillez noter que toutes les commandes ouvertes seront annulées à la fin des activités le 13 novembre 2020. Les concessionnaires sont invités à saisir à nouveau leurs commandes.

Effective Date/ Date effective :

Le 16 novembre/November 2020

New Symbol/ Nouveau symbole :

LOBE

Old Symbol/Vieux symbole:

GSTR

New CUSIP/ Nouveau CUSIP :

53946V107

New ISIN/ Nouveau ISIN :

CA53946V1076

Old/Vieux CUSIP & ISIN :

39574M105/CA39574M1059

 

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com

Pour toute question, pour obtenir de l'information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l'adresse: Listings@thecse.com

News Provided by Newsfile via QuoteMedia

Lobe Sciences

Lobe Sciences Investor Kit

  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

The Conversation (0)
Lobe Sciences (CSE:LOBE,OTCQB: LOBEF)

Lobe Sciences

Entering Clinical Stage Development for Proprietary Patent-pending Psilocin Compounds

Entering Clinical Stage Development for Proprietary Patent-pending Psilocin Compounds Keep Reading...
Cannabis plant in focus, blurred US flag background.

Analysts React: Trump Signs Executive Order to Reschedule Cannabis

The long-debated issue of US cannabis rescheduling is finally back in the spotlight. On Thursday, December 18, President Donald Trump signed an executive order to expedite the process of moving cannabis from Schedule I to Schedule III under the Controlled Substances Act. Market watchers are now... Keep Reading...
Close-up of green cannabis leaves in natural light.

Trump Weighs Executive Order to Loosen Federal Cannabis Restrictions

US President Donald Trump is reportedly weighing a major shift in federal drug policy that would relax decades-old restrictions on cannabis, potentially injecting new life into the industry. Six people familiar with the discussions told the Washington Post that Trump is preparing an executive... Keep Reading...
Gavel on a surface with scattered cannabis leaves, symbolizing legal issues around marijuana.

Hemp THC Recriminalization: A Blow to a Blooming Industry

A spending bill to reopen the US government after a 43 day shutdown includes provisions that will recriminalize most hemp-derived THC products. This change, slated to become effective one year after enactment, in late 2026, marks a significant policy reversal from the 2018 Farm Bill, which... Keep Reading...
Cannabis buds on a wooden surface with Australian banknotes nearby.

Australia's Cannabis Import Quota Slashed Amid Surging Local Production

Australia’s Office of Drug Control (ODC) said the country’s 2025 cannabis import quota has been reduced by the International Narcotics Control Board from 101 tonnes to 88 tonnes, Business of Cannabis reported.Over-projected demand and idle permits that limited operational flexibility were cited... Keep Reading...
Gavel resting on cannabis leaves.

Cannabis Crossroads: Record US Demand Meets Federal Gridlock

The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
Cannabis leaf.

10 Biggest Cannabis Stocks in the US and Canada in 2025

After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...
Lobe Sciences

Lobe Sciences Investor Kit

  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

Interactive Chart

Latest Press Releases

Related News